Abstract
The observations of Janoff et al. (1970) and Marks et al. (1982) that the application of the tumor promoter TPA induces cytotoxicity, inflammation, and vascular permeability changes provided the basis for inquiry into the involvement of arachidonate metabolites in such manifestations and in the tumor promotion process. Mouse skin is one of the more commonly used organs in experimental carcinogenesis studies and has proved to be one of the best model systems for studying the multistage nature of carcinogenesis (Berenblum and Shubik 1947; Slaga et al. 1980a, 1981a). Skin tumors in mice can be readily induced by the sequential application of a subthreshold dose of a carcinogen (initiation stage) followed by repetitive treatment with a noncarcinogenic tumor promoter (promotion stage). Promotion is most often accomplished by using 12-O-tetradecanoyl phorbol-13-acetate (TPA), although a variety of agents have been identified as skin tumor promoters, including benzoyl peroxide, anthralin, and dihydroteleocidin B (Slaga 1984). Promotion can be further subdivided such that the appropriate sequential use of incomplete or partial promoters such as the calcium ionophore A-23187 (first stage promoter) and mezerein (second stage) can supplant the use of a complete promoter.
This work wa supported by NIH Grants CA-34443 and CA-42211.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Abbreviations
- TPA:
-
12-O-tetradecanoyl phorbol-13-acetate
- ODC:
-
ornithine decarboxylase
- PGs:
-
prostaglandins
- NDGA:
-
nordihydroguaiaretic acid
- HETE:
-
hydroxyeicosatetraenoic acid
- HPETE:
-
hydroperoxyeicosatetraenoic acid
- SOD:
-
superoxide dismutase
- CuDIPS = Cu(II)(3,4:
-
diisopropyl salicylic acid)2
- CL:
-
chemiluminescence.
References
Belman S, Troll W (1972) The inhibition of croton oil-promoted mouse skin tumorigenesis by steroid hormones. Cancer Res 32: 450–454
Berenblum I, Shubik P (1947) A new quantitative approach to the study of the stages of chemical carcinogenesis in the mouse skin. Br J Cancer 1:383 –391
Bresnick E, Meunier P, Lamden M (1979) Epidermal prostaglandins after topical application of a tumor promoter. Cancer Lett 7: 121–125
Bors W, Saran M, Michel C (1983) Assays of oxygen radicals: methods and mechanisms. In: Oberley LW (ed) Superoxide Dismutase, vol 2. CRC Boca Raton, pp 31–63
Danaika J, Ichikawa A, Okada M, Tomita A (1984) Calcium dependency of inhibition by arachidonic acid of Compound 48/80-induced histamine release from mast cells. Biochem Pharmacol 33: 1653–1659
DeChatelet LR, McCall CE, McPhail LC, Johnston RB (1974) Superoxide dismutase activity in leukocytes. J Chem Invest 53: 1197–1201
Fischer SM (1983) The role of prostaglandins in tumor promotion. In: Slaga TJ (ed) Mechanisms of Tumor Promotion, vol II. Tumor Promotion and Skin Carcinogenesis. CRC Boca Raton, pp 113–126
Fischer SM, Adams LA (1985) Tumor promoter-induced chemiluminescence in mouse epidermal cells is inhibited by several inhibitors of arachidonic acid metabolism. Cancer Res 45:3130– 3136
Fischer SM, Slaga TJ (1982) Modulation of prostaglandin synthesis and tumor promotion. In: Powles TJ et al. (eds) Prostaglandins and Cancer First International Conf. Alan R Liss, New York, pp 255–264
Fischer SM, Gleason GL, Bohrman JS, Slaga TJ (1980a) Prostaglandin modulation of phorbol ester skin tumor promotion. Carcinogenesis (Lond) 1: 245–248
Fischer SM, Gleason GL, Mills GD, Slaga TJ (1980b) Indomethacin enhancement of TPA tumor promotion in mice. Cancer Lett 10: 343–350
Fischer SM, Mills GD, Slaga TJ (1982) Inhibition of mouse skin tumor promotion by several inhibitors of arachidonic acid metabolism. Carcinogenesis (Lond) 3: 1243–1245
Fischer SM, Mills GD, Slaga TJ (1983) In: Samuelsson B, Paoletti R, Ramwell P (eds) Adv Prostaglandin, Thromboxane and Leukotriene Research, vol 12. Raven, New York, pp 309–312.
Fischer SM, Baldwin JK, Adams LM (1985) Phospholipase C mimics tumor-promoter induced chemiluminescence in murine epidermal cells. Biochem Biophys Res Commun 131: 1103–1108
Fischer SM, Baldwin JK, Adams LM (1986) Effects of anti-promoters and strain of mouse on tumor promoter-induced oxidants in murine epidermal cells. Carcinogenesis 7: 915–918
Fürstenberger G, Marks F (1982) Studies on the role of prostaglandins in the induction of cell proliferation and hyperplasia and in tumor promotion in mouse skin. In: Hecker E et al. (eds) Symp on Cocareinogenesis and Biological Effects on Tumor Promoters. Raven, New York, pp 325–330
Fürstenberger G, Marks F (1985) Prostaglandins, epidermal hyperplasia and skin-tumor promotion. In: Fischer SM, Slaga TJ (eds) Arachidonic acid metabolism and tumor promotion, Martinus Nijhoff, Boston, pp 49–72
Gryglewski RJ (1979) Effects of anti-inflammatory steroids on arachidonate cascade. In: Weissman G et al. (eds) Adv Inflammation Res, vol 1. Raven, New York, p 505
Hamberg M, Samuelsson B (1974) Prostaglandin endoperoxides. Novel transformations of arachidonic acid in human platelets. Proc Natl Acad Sci USA 71: 3400–3404
Hammarström S, Hamberg M, Samuelsson B, Duell E, Stawiski M, Vorhees J J (1975) Increased concentrations of nonesterifled arachidonic acid, 12L-hydroxy 5,8,10,14-eicosatetraenoic acid, prostaglandin E2 and prostaglandin F2α in epidermis of psoriasis. Proc Natl Acad Sci USA 72: 5130–5134
Hong SL, Levine L (1976) Inhibition of arachidonic acid release from cells as the biochemical action of anti-inflammatory corticosteroids. Proc Natl Acad Sci USA 73: 1730–1734
Janoff A, Klassen A, Troll W (1970) Local vascular changes induced by the cocarcinogen phorbol myristate acetate. Cancer Res 30: 2568
Jeng AY, Licht U, Strickland JE, Blumberg PM (1985) Similar effects of phospholipase C and phorbol ester tumor promoters on primary mouse epidermal cells. Cancer Res 45: 5714–5721
Kato R, Nakadate T, Yamamoto S, Sugimura T (1983) Inhibition of 12-O-tetradecanoylphorbol- 13-acetate-induced tumor promotion and ornithine decarboxylase activity by quercetin: possible involvement of lipoxygenase inhibition. Carcinogenesis (Lond) 4: 1301–1035
Kato R, Nakadate T, Yamamoto S (1984) Involvement of lipoxygenase products of arachidonic acid in tumor-promoting activity of TPA. In: Thaler-Dao et al. (eds) Icosanoids and Cancer. Raven, New York, pp 101–113
Kensler TW, Trush MA (1981) Inhibition of phorbol ester stimulated chemiluminescence in human polymorphonuclear leukocytes by retinoic acid and 5,6 epoxyretinoic acid. Cancer Res 41: 216–222
Kensler TW, Trush MA (1983) Inhibition of oxygen radical metabolism in phorbol ester-activated polymorphonuclear leukocytes by an antitumor promoting copper complex with superoxide dismutase mimetic activity. Biochem Pharmacol 32: 3485–3487
Kensler TW, Bush DM, Kozumbo WJ (1983) Inhibition of tumor promotion by a biomimetic superoxide dismutase. Science 221: 75–77
Kondoh H, Sato Y, Kanoh H (1985) Arachidonic acid metabolism in cultured mouse keratinocytes. J Invest Dermatol 85: 64–69
Marks F, Berry DL, Bertsch S, Fürstenberger G, Richter H (1982) On the relationship between epidermal hyperproliferation and skin tumor promotion. In: Hecker E et al. (eds) Cocarcinogenesis and biological effects of tumor promoters. Raven, New York, pp 331 — 346
Nakadate T, Yamamoto S, Iseki H, Sonoda S, Takemura S, Ura A, Hosoda Y, Kato R (1982) Inhibition of 12-0-tetradecanoylphorbol-13-acetate-induced tumor promotion by nordihydroguaia- retic acid, a lipoxygenase inhibitor and p-bromophenacyl bromide, a phospholipase A2 inhibitor. Gann 73: 841–843
Nishisuka Y (1984) The role of protein kinase C in cell surface signal transduction and tumour promotion. Nature 308: 693–698
Reiners JJ, Nesnow S, Slaga TJ (1985) Murine susceptibility to two-stage carcinogenesis is influenced by the agent used for promotion. Carcinogenesis (Lond) 5: 301 — 307
Schwartz JA, Viaje A, Slaga TJ, Yuspa SH, Hennings H, Lichti U (1977) Fluocinolone acetonide: A potent inhibitor of mouse skin tumor promotion and epidermal DNA synthesis. Chem Biol Interact 17: 331–347
Slaga TJ (1984) Mechanisms involved in two-stage carcinogenesis in mouse skin. In: Slaga T (ed) Mechanism of tumor promotion. CRC, Boca Raton, pp 1–16
Slaga TJ, Fischer SM, Viaje A, Berry DL, Bracken WM, LeClerc S, Miller DL (1978) Inhibition of tumor promotion by anti-inflammatory agents: an approach to the biochemical mechanism of promotion. In: Slaga TJ, Sivak A, Boutwell RK (eds) Carcinogenesis, Mechanisms of Tumor Promotion and Cocarcinogenesis, vol 2. Raven, New York, pp 173–195
Slaga TJ, Fischer SM, Nelson K, Gleason GL (1980a) Studies on the mechanism of skin tumor promotion: evidence for several stages in promotion. Proc Natl Acad Sci USA 77:3659– 3663
Slaga TJ, Fischer SM, Weeks CE, Klein-Szanto AJP (1980b) Multistage chemical carcinogenesis. In: Seije M, Bernstein IA (eds) Biochemistry of Normal and Abnormal Epidermal Differentiation. Univ Tokyo Press, Tokyo, pp 193–218
Slaga TJ, Klein-Szanto AJP, Fischer SM, Weeks CE, Nelson K, Major S (1980c) Studies on the mechanism of action of anti-tumor promoting agents: Their specificity in two-stage promotion. Proc Natl Acad Sci USA 77: 2251–2254
Slaga TJ, Fischer SM, Weeks CE, Klein-Szanto AJP (1981a) In: Hodgson E, Bend JR, Philpot RM (eds) Rev Biochem Tox. Elsevier/North Holland, New York, pp 231–282
Slaga TJ, Klein-Szanto AJP, Triplett LL, Yotti LP (1981b) Skin tumor-promoting activity of benzoyl peroxide, a widely used free radical-generating compound. Science 213: 1023–1025
Slaga TJ, Solanki V, Logani M (1983) Studies on the mechanism of action of antitumor promoting agents: Suggestive evidence for the involvement of free radicals in promotion. In: Radio protectors and anticarcinogens. Academic Press, London, pp 471–485
Smith RL, Weidemann MJ (1980) Reactive oxygen production associated with arachidonic acid metabolism by peritoneal macrophages. Biochem Biophys Res Commun 97: 973–980
Solanki V, Rana RS, Slaga TJ (1981) Diminution of mouse superoxide dismutase and catalase activities by tumor promoters. Carcinogenesis (Lond) 2: 1141–1146
Trash MA, Wilson ME, Van Dyke K (1978) The generation of chemiluminescence by phagocytic cells. Methods Enzymol 57: 462–494
Verma AK, Rice HM, Boutwell RK (1977) Prostaglandins and skin tumor promotion: Inhibition of tumor promoter-induced ornithine decarboxylase activity in epidermis by inhibitors of prostaglandin synthesis. Biochem Biophys Res Commun 79: 1160–1166
Verma AK, Ashendel CL, Boutwell RK (1980) Inhibition by prostaglandin synthesis inhibitors of the induction of epidermal ornithine decarboxylase activity, the accumulation of prostaglandins and tumor promotion caused by 12-0-tetradecanoyl-phorbol-13-acetate. Cancer Res 40: 308–315
Witz G, Goldstein BD, Amdruso M, Stone DS, Troll W (1980) Retinoid inhibition of superoxide anion radical production by human polymorphonuclear leukocytes stimulated with tumor pro-moters. Biochem Biophys Res Commun 97: 883–888
Yotti LP, Chang CC, Trosko JE (1979) Elimination of metabolic cooperation in Chinese hamster cells by a tumor promoter. Science 206: 1989–1091
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1987 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Fischer, S.M. (1987). The Arachidonate Cascade and Mouse Skin Tumor Promotion. In: Garaci, E., Paoletti, R., Santoro, M.G. (eds) Prostaglandins in Cancer Research. Proceedings in Life Sciences. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-71904-2_4
Download citation
DOI: https://doi.org/10.1007/978-3-642-71904-2_4
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-71906-6
Online ISBN: 978-3-642-71904-2
eBook Packages: Springer Book Archive